Ranbaxy Laboratories Ltd.
Ranbaxy Laboratories Ltd.
- Mkt Cap (₹ Cr.)
- P/E (x)
- P/B (x)
- Div_ Yield (%)
- BETABETA1 Month3-Months6-Months1 Year3-Years
- Face Value (₹)5.00
- EPS-TTM (Rs.)-3.19
- BV/share (₹)77.93
- 52Wk L/H359.00/ 870.00
- Avg. Daily Volatility %Avg. Daily Volatility %1 Month3-Months6-Months1 Year3-Years
Ranbaxy Laboratories Ltd. Share Price Updates
Ranbaxy Laboratories Ltd. Quarterly Results
Ranbaxy Laboratories Ltd Share Price
Ranbaxy Laboratories Ltd Risk Return Comparisonwith peersNew
Ranbaxy Laboratories Ltd Financial Comparisonwith peers
Ranbaxy Laboratories Ltd Share Holding as on 31-12-2014
|Category||No. of shares||Percentage|
MF Ownership Of Ranbaxy Laboratories Ltd. Shares
About Ranbaxy Laboratories Ltd.
Ranbaxy Laboratories Ltd., incorporated in the year 1961, is a Large Cap company (having a market cap of Rs 1561.96 Crore) operating in General sector.
Ranbaxy Laboratories Ltd. key Products/Revenue Segments include Tablets which contributed Rs 3188.65 Crore to Sales Value (46.15 % of Total Sales), Active Pharma Ingredients which contributed Rs 1179.15 Crore to Sales Value (17.06 % of Total Sales), Capsules which contributed Rs 840.36 Crore to Sales Value (12.16 % of Total Sales), Others which contributed Rs 638.36 Crore to Sales Value (9.23 % of Total Sales), Vials which contributed Rs 531.84 Crore to Sales Value (7.69 % of Total Sales), Ointments which contributed Rs 322.70 Crore to Sales Value (4.67 % of Total Sales), Export Incentives which contributed Rs 88.64 Crore to Sales Value (1.28 % of Total Sales), Other Operating Revenue which contributed Rs 55.61 Crore to Sales Value (0.80 % of Total Sales), Royalty Income which contributed Rs 50.34 Crore to Sales Value (0.72 % of Total Sales), Scrap which contributed Rs 12.28 Crore to Sales Value (0.17 % of Total Sales) and Insurance Claims which contributed Rs 1.02 Crore to Sales Value (0.01 % of Total Sales)for the year ending 31-Mar-2014.
For the quarter ended 31-12-2014, the company has reported a Standalone sales of Rs 956.52 Crore, down -24.84 % from last quarter Sales of Rs 1272.69 Crore and down -27.95 % from last year same quarter Sales of Rs 1327.64 Crore Company has reported net profit after tax of Rs -1420.48 Crore in latest quarter.
The company’s top management includes Dr.Anthony H Wild, Dr.Kazunori Hirokawa, Dr.Tsutomu Une, Mr.Akihiro Watanabe, Mr.Arun Sawhney, Mr.Percy K Shroff, Mr.Rajesh V Shah, Mr.Takashi Shoda. Company has BSR & Co. as its auditors As on 31-12-2014, the company has a total of 425,022,900 shares outstanding.